Metavasi Capital LP Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001864835

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHigh Turnover how tags are computed

Q1 2026 · 21 positions · Total reported value $276.29M · Top-10 concentration 81.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 86.5% · 13 new · 7 cut · 12 exited

Active Share (vs S&P 500): 94.4% · vs QQQ: 93.6% — share of the book that differs from index weights (higher = more active) · ranking

In its Q1 2026 13F filing, Metavasi Capital LP disclosed 21 equity positions with a combined reported value of $276.29M. The filing implies a focused portfolio: its ten largest positions account for 81.0% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.

The largest disclosed positions as of Q1 2026 were TLT ($108.32M), APP ($24.34M), DAVE ($20.47M). By sector, the heaviest allocations are Consumer Discretionary 24.5%, Technology 15.1%. Versus the prior quarter, allocation shifted toward Other (+28.1pp), Health Care (+3.4pp) and away from Energy (-0.8pp), Consumer Discretionary (-5.4pp).

Versus the prior quarter, Metavasi Capital LP opened 13 new positions, trimmed 7 and fully exited 12, a turnover rate of 86.5% of positions. The portfolio's overlap with the prior quarter was 55% of names.

The largest new positions opened in Q1 2026 were SPOT ($11.01M), AKAM ($5.95M), TWST ($4.75M).

Of the 12 positions fully exited versus the prior quarter, the largest were BLND ($19.41M), TWLO ($12.46M), CPNG ($6.34M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • SPOT SPOTIFY TECHNOLOGY S A · $11.01M
  • AKAM AKAMAI TECHNOLOGIES INC · $5.95M
  • TWST TWIST BIOSCIENCE CORP · $4.75M
  • HIMS HIMS & HERS HEALTH INC · $4.61M

Fully Exited (vs previous quarter)

  • BLND BLEND LABS INC · prev qtr: $19.41M
  • TWLO TWILIO INC · prev qtr: $12.46M
  • CPNG COUPANG INC · prev qtr: $6.34M
  • RKT ROCKET COS INC · prev qtr: $5.42M
  • WING WINGSTOP INC · prev qtr: $5.15M
  • RDDT REDDIT INC · prev qtr: $4.60M
  • EVLV EVOLV TECHNOLOGIES HLDNGS IN · prev qtr: $4.52M
  • SE SEA LTD · prev qtr: $4.46M

Insider Transactions (Form 4)

Latest Metavasi Capital LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Metavasi Capital LP, based in Larchmont, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 25 positions worth $282.53M in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: LARCHMONT, NY, United States
  • SEC registration: 801-120146 (status: Approved), registered 2021-01-13
  • Regulatory AUM (Form ADV): $420.59M as of 2026-03-17
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 1 hedge funds

Portfolio Structure

  • 25 positions · $282.53M reported value (Q3 2026)
  • Top 10 holdings = 63.0% of reported value
  • Largest position: DAVE (DAVE INC) at 10.6%
  • Average position size: $11.30M

Sector Tilt

  • Financials 28.0%
  • Information Technology 25.9%
  • Consumer Discretionary 20.3%
  • (classified holdings cover 83% of value)

Quarterly Activity

  • Q3 2026: 13 new, 5 added, 7 reduced, 12 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 15.1%
Financials 14.3%
Energy 2.8%
Other 39.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.25M $108.32M 39.20%
39.20%
Add
2 61.17K $24.34M 8.81%
8.81%
Add
3 117.59K $20.47M 7.41%
7.41%
Add
4 82.12K $12.33M 4.46%
4.46%
Add
5 122.27K $11.91M 4.31%
4.31%
Reduce
6 98.11K $11.52M 4.17%
4.17%
Reduce
7 22.71K $11.01M 3.99%
3.99%
New
8 26.00K $8.17M 2.96%
2.96%
Add
9 58.03K $7.86M 2.85%
2.85%
Reduce
10 66.00K $7.73M 2.80%
2.80%
Add
11 1.04M $7.57M 2.74%
2.74%
Reduce
12 106.79K $7.40M 2.68%
2.68%
Hold
13 51.80K $5.95M 2.15%
2.15%
New
14 54.23K $5.74M 2.08%
2.08%
Reduce
15 250.00K $5.49M 1.99%
1.99%
Add
16 125.00K $5.11M 1.85%
1.85%
Add
17 100.00K $4.75M 1.72%
1.72%
New
18 222.00K $4.61M 1.67%
1.67%
New
19 279.48K $4.02M 1.45%
1.45%
Reduce
20 382.30K $1.98M 0.72%
0.72%
Reduce
21 481.77K $4.82K 0.00%
0.00%
Hold

FAQ

What did Metavasi Capital LP buy in 2026-Q1?

In its 2026-Q1 13F filing, Metavasi Capital LP reported 21 equity positions worth $276.29M in aggregate; its largest disclosed positions were TLT ($108.32M), APP ($24.34M), DAVE ($20.47M).

How large is Metavasi Capital LP's portfolio?

Metavasi Capital LP reported $276.29M of long equity holdings across 21 positions as of 2026-Q1. Top-10 holdings account for 81.0% of reported value.

What is Metavasi Capital LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/metavasi-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →